| 发明名称 |
GENE THERAPEUTIC AGENT |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a new gene therapeutic agent having neovascularization actions. <P>SOLUTION: A gene encodes a polypeptide having both an amino acid sequence of a polypeptide having a fibroblast growth factor activity and an amino acid sequence of a polypeptide having a cell adhesion activity. A medicine is composed of the gene. A vector has the gene. The medicine is composed of the vector. The polypeptide has an amino acid sequence of a secretory signal and both the amino acid sequence of the polypeptide having the fibroblast growth factor activity and the amino acid sequence of the polypeptide having the cell adhesion activity. The medicine is composed of the polypeptide. The gene encodes the polypeptide. The medicine is composed of the gene. The vector has the gene. The medicine is composed of the vector. <P>COPYRIGHT: (C)2005,JPO&NCIPI |
| 申请公布号 |
JP2005052001(A) |
申请公布日期 |
2005.03.03 |
| 申请号 |
JP20010204300 |
申请日期 |
2001.07.05 |
| 申请人 |
TAKARA BIO INC |
发明人 |
TANAKA KEIJI;CHONO HIDETO;MORISHITA MIO;KONISHI HARUKO;UENO MITSUHIRO;ASADA KIYOZOU;KATO IKUNOSHIN |
| 分类号 |
C12N15/09;A61K35/76;A61K38/00;A61K38/22;A61K48/00;A61P9/00;A61P9/10;A61P19/00;A61P19/08;A61P43/00;C07K14/50;C07K14/78;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/02 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
